Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii

BACKGROUND: We retrospectively analyzed the effect of tigecycline and cefoperazone/sulbactam therapies on the prognosis of patients with carbapenem-resistant Acinetobacter baumannii bloodstream infection (CRAB-BSI). METHODS: CRAB-BSI patients receiving tigecycline therapy or cefoperazone/sulbactam t...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Tianshui, Luo, Qixia, Li, Yaqing, Zhou, Yanzi, Yu, Wei, Xiao, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404342/
https://www.ncbi.nlm.nih.gov/pubmed/30886705
http://dx.doi.org/10.1186/s13756-019-0502-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404342/
https://www.ncbi.nlm.nih.gov/pubmed/30886705
http://dx.doi.org/10.1186/s13756-019-0502-x

Ejemplares similares